JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

[Medical treatment for osteoporosis with pulmonary disorders-from a viewpoint of an endocrinologist-.]

Today, we can treat osteoporotic patients with multiple drugs of various mechanisms and in various forms. Nevertheless, there exist few clinical evidences that exhibit an efficacy of an anti-osteoporotic drug on osteoporosis with pulmonary disorders, including asthma, COPD and OSAS. We should use drugs for osteoporotic patients with pulmonary disorders in accordance with a guideline on the management and treatment of glucocorticoid-induced osteoporosis or a guideline on the management and treatment of osteoporosis, according to whether they are treated by glucocorticoid or not.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app